Nasal Colonization With Staph Bacteria Linked to Acute Radiation Dermatitis
FRIDAY, May 12, 2023 (HealthDay News) — Nasal colonization with Staphylococcus aureus (SA) before radiation therapy (RT) is associated with acute radiation dermatitis (ARD) severity, and bacterial decolonization (BD) is effective for ARD prophylaxis,…
Learn MoreAI Algorithms Trained on Fundus Photographs Infer Self-Reported Race
FRIDAY, May 12, 2023 (HealthDay News) — Artificial intelligence (AI) algorithms trained on fundus photographs infer the self-reported race (SRR) of infants, regardless of whether the images contain color, according to a study published online May 4 i…
Learn More1999 to 2018 Saw Increase in Cancer Survivors With Functional Limitation
THURSDAY, May 11, 2023 (HealthDay News) — From 1999 to 2018, there was a more than twofold increase in the number of cancer survivors reporting functional limitations, according to a research letter published online May 11 in JAMA Oncology.Vishal R. …
Learn MoreDog Walking-Associated Injury Burden Is Considerable, Increasing
THURSDAY, May 11, 2023 (HealthDay News) — Dog walking is associated with a considerable injury burden, according to a study published online April 14 in Medicine & Science in Sports & Exercise.Ridge Maxson, from Johns Hopkins University School of Med…
Learn MoreWomen Have About 12-Year Delay in Onset of Atherosclerosis
THURSDAY, May 11, 2023 (HealthDay News) — Women have an approximately 12-year delay in the onset of coronary atherosclerosis, but those in the highest atherosclerotic burden group have a higher risk for major adverse cardiovascular events (MACE), acc…
Learn MoreCabozantinib Plus Nivolumab and Ipilimumab Increases PFS in Renal Cell Cancer
THURSDAY, May 11, 2023 (HealthDay News) — Cabozantinib plus nivolumab and ipilimumab yields significantly longer progression-free survival than treatment with cabozantinib plus nivolumab alone among patients with previously untreated, advanced renal-…
Learn MoreVenetoclax-Obinutuzumab With, Without Ibrutinib Superior in Leukemia
THURSDAY, May 11, 2023 (HealthDay News) — For fit patients with chronic lymphocytic leukemia (CLL), venetoclax-obinutuzumab with or without ibrutinib, is superior to chemoimmunotherapy as first-line treatment, according to a study published in the Ma…
Learn MoreImmunotherapy Works Well for Young Children With Peanut Allergy
WEDNESDAY, May 10, 2023 (HealthDay News) — For children aged 1 to 3 years with peanut allergy, epicutaneous immunotherapy for 12 months is superior for desensitizing children to peanuts, according to a study published in the May 11 issue of the New E…
Learn MoreLink Between Gestational Weight Gain, Autism Spectrum Disorder in Offspring Explored
WEDNESDAY, May 10, 2023 (HealthDay News) — For children with greater predisposition to autism-related behaviors and who have mothers with prepregnancy overweight or obesity, gestational weight gain (GWG) is associated with autism spectrum disorder (A…
Learn MorePharmacologic Therapies Effective for Excessive Daytime Sleepiness
WEDNESDAY, May 10, 2023 (HealthDay News) — For patients with obstructive sleep apnea (OSA), solriamfetol, armodafinil-modafinil, and pitolisant reduce daytime sleepiness, with solriamfetol likely superior, according to a systematic review and meta-an…
Learn More